Endocrinology Weekly Update - September 29th 2025
Endocrinology Update: Once-Weekly Kyinsu, Bayer’s Lynkuet, EASD’s clinical…
Obesity Weekly News - September 16th 2025
Obesity Update: ASC30’s Ultra-Long Dosing, Oral GLP-1 Pill Race, Korea…
Artificial Intelligence and Digital Health Weekly News - September 11th 2025
AI & Digital Health Update – Sep 11, 2025: China BCI plan, £118M AI vax,…
Obesity Weekly News - August 19th 2025
Obesity Update: Enobosarm’s Oral Release, AI-Powered Drug Discovery, £85M…
Obesity Weekly News - August 12th 2025
Obesity Update: Ascletis’ ASC30, Hanmi’s CRF2 Breakthrough, Orforglipron’s…
Obesity Weekly News - August 5th 2025
Obesity Update: Radella’s MD-18, Korglutide’s Oral Entry, Liraglutide Launches,…
Obesity Weekly News - July 22nd 2025
Obesity Update: CGX-926 Oral Debut, 18% Weight Loss from KAI-9531, Vivani’s…
Obesity Weekly News - July 1st 2025
Fractyl’s Gene Therapy Breakthrough, Verdiva’s Oral GLP-1 Pipeline, Viking’s…
Obesity Weekly News - June 24th 2025
Eccogene’s Oral GLP-1 Debut, Novo’s 24% Weight Loss Win, Lilly’s Q3 Reveal…
Obesity Weekly News - June 17th 2025
Obesity 🚨 Breakthroughs in Obesity Drug Development You Need to Know! In this…
Obesity Weekly News - June 10th 2025
Obesity Advancements: Arrowhead’s RNAi Debut, Lilly’s $870M Bet, Novo’s Triple…
Obesity Weekly News - June 3rd 2025
Obesity Advancements: Regeneron’s Triplet Breakthrough, $2B Hansoh Deal,…